Low T Or High Risk? Testosterone Treatments And Heart Attacks

Jan 29 2014, 10:52pm CST | by

Maybe ‘Low T’ is something men may want to live with, after all. A new study finds that treatments for boosting low testosterone levels – which pervasive marketing warns can interfere with sex drive, moods and energy – may increase the risk of heart attacks in large swathes of men.

Specifically, the risk doubled during the first three months after starting therapy in men younger than 65 years old who had a history of heart disease. Similarly, the risk also doubled for all men older than 65 – those with or without heart disease – shortly after beginning treatment, according the study published in PLOS One.

At first blush, this may not seem to be heart-stopping news. Previous studies have suggested such therapies – including the widely touted AndroGel that is sold by AbbVie – can increase cardiovascular risk. In fact, a small study published in The New England Journal of Medicine three years ago reached such a conclusion (read this).

But the latest study is different and, consequently, may have the potential to change the conversation about the extent to which using testosterone treatments is desirable. And the results are prompting calls for the FDA to update product labeling (see this, this and this) in order to flag cardiovascular concerns.

Why? Unlike earlier efforts, the latest study examined a large population. The researchers culled records of 55,593 men who had been prescribed testosterone treatments, including 48,539 who were younger than 65 years old. The data was obtained from Truven Health Analytics, which aggregates patient records.

“Due to the size of our study, we were able to examine heart attacks, as opposed to a variety of cardiovascular conditions, and we were able to examine excess risk in the short term,” says William Finkle, the lead author and an epidemiologist at Consolidated Research, a statistics and software development firm. “Our study is also the first to include a substantial number of men under 65″ (here is the study).

An AbbVie spokesman did not respond to a request for comment.

The researchers also compared patients given testosterone treatments – which include the Axiron solution sold by Eli Lilly and the Androderm patch marketed by Actavis – with those given the Viagra and Cialis erectile dysfunction pills, since these are similarly prescribed for enhancing sexual performance.

Here, they found that men younger than 65 who were given testosterone boosters and had a history of heart disease were twice as likely to suffer a heart attack, relative to the impotence pills. The implication is that the increase in cardiovascular risk is due to the treatments, not the sexual behavior.

The findings come amid years of aggressive promotion of testosterone treatments. A study published last fall in the Journal of the American Medical Association noted that annual prescriptions for these elixirs rose more than five-fold from 2000 to 2011, reaching 5.3 million prescriptions. Sales totaled nearly $2 billion in 2012, according to IMS Health, the research firm.

The marketing has sometimes been controversial. Four years ago, a study in The New England Journal of Medicine found only 2 percent of men aged 40 to 80 suffered from ‘Low T,’ which is sometimes called male menopause, but the web site run by Abbott Laboratories (and now by AbbVie) was criticized for overstating the case.

And two years ago, a group of physicians and academics complained to the independent Pharmaceutical Advertising Advisory Board in Canada that an AndroGel campaign harmed public health by promoting unapproved uses and implying exaggerated effectiveness.

Consequently, the PLOS authors recommend further studies that can “assess the range of benefits and risks.” Although Sid Wolfe of Public Citizen Health Research Group believes the FDA should not wait to update the product labeling to reflect the risk of heart attacks.

“This study adds an enormous amount to what is known about the risks,” he argues. “It’s an important breakthrough and the implications are sobering, but unfortunately, there is nothing in the current labeling or the med guides for patients.”

Source: Forbes Business

 
 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

China pledges $81 mn financial assistance for Afghanistan
Beijing, Oct 31 (IANS) China Friday pledged to provide non-reimbursable assistance of 500 million yuan (about 81 million dollars) to Afghanistan this year at an international meeting on Afghanistan held here.
 
 
EU seeks talks with Russia over goods duties: WTO
Geneva, Oct 31 (IANS) The European Union (EU) has sought a consultation with Russia over the tariffs the latter imposed on certain agricultural and manufactured goods, the World Trade Organisation (WTO) said Friday.
 
 
Virgin Galactic's spaceship crashes during test flight
Los Angeles, Nov 1 (IANS) A passenger rocket plane developed by Virgin Galactic's crashed Friday after suffering an "in-flight anomaly" during a powered test flight over the US state of California, the company said.
 
 
Bhopal fugitive Warren Anderson is dead (Roundup, Changing dateline)
Washington, Oct 31 (IANS) Warren Anderson, the former CEO of Union Carbide Corp, has died at 92 after living for 30 years under the shadow of the 1984 Bhopal gas tragedy that killed thousands.
 
 
 

Latest from the Network

Arnold Schwarzenegger 'knew' he'd star in another Terminator movie
Arnold Schwarzenegger ''always knew'' he'd star in another 'Terminator' movie. The 67-year-old actor - the former governor of California - insists he wasn't surprised when he got a call from producers to appear in the...
Read more on Movie Balla
 
Anne Hathaway would 'love' a sequel to The Devil Wears Prada
Anne Hathaway would ''love'' to appear in a sequel to 'The Devil Wears Prada'. The Oscar-winning actress starred in the popular 2006 comedy-drama, which also featured Meryl Streep and Emily Blunt, and has revealed she...
Read more on Movie Balla
 
Lily Aldridge wearing mother's Playboy costume for Halloween
Lily Aldridge will wear her mother's old Playboy costume for Halloween. The 28-year-old model - who is married to Kings of Leon singer Caleb Followill - found her mum Laura Lyons' raunchy Playboy Bunny flight attendant...
Read more on Celebrity Balla
 
Rochelle Humes' daughter loves Marvin doll
Rochelle Humes is embarrassed by her daughter's obsession with a doll of her husband, Marvin Humes. The 25-year-old singer has admitted she found it ''cringey'' when she was recently photographed holding a doll of her...
Read more on Celebrity Balla
 
Keira Knightley annoyed Chloe Moretz didn't ask her advice
Keira Knightley was annoyed Chloe Grace Moretz didn't want her advice. The 29-year-old actress - who appears alongside the 17-year-old star in her latest movie 'Say When' - was disappointed that the young actress didn'...
Read more on Celebrity Balla
 
Daniel Radcliffe loses everything
Daniel Radcliffe loses everything. The 'Horns' star admits he constantly has to replace his mobile phone and often puts things away and can't ever find them again. The 25-year-old actor said: ''I lose things a lot. At...
Read more on Celebrity Balla
 
Apple Outsmarts Samsung in Terms of Revenue Generation
Samsung can sell more products, but it doesn’t mean that it will earn more profit, as Apple overtakes the Korean giant with respect to the earnings.According to the Cult of Mac, Samsung earned a profit of $3.8 billion...
Read more on Apple Balla
 
Apple Declares Not to Remove PCalc iOS Calculator Widget
The PCalc iOs calculator widget is free from the risk of being removed, as Apple decides not to drop it from the App Store.According to Tech Crunch, the officials of Apple have confirmed about the move, stating that it...
Read more on Apple Balla
 
Seth Rogen to Act as Steve Wozniak in the Steve Jobs’ Movie
Seth Rogen has got an important role in the biopic of the late Apple co-founder Steve Jobs, as he has been selected to play as Steve Wozniak.According to the Variety, Rogen will be advised directly by Steve Wozniak, the...
Read more on Apple Balla
 
Ponzy schemer cheats residents of $22 mn, gets 15-year jail
Washington, Oct 31 (IANS) If you have been one of those approached by some 'known' person for investing in something with an assurance of 'easy money', you may benefit reading about this Ponzi schemer jailed in the US...
Read more on Politics Balla